Dalan Huang, President of C.S. Group, emphasized that superior raw materials are the prerequisite for high-quality finished products. This is why we must first prioritize the optimization of elite strains and the scaling of our cultivation processes. By building a solid foundation in these two areas, we can effectively perform the extraction and purification of bioactive compounds, ultimately facilitating our entry into the biopharmaceutical sector.
https://www.prnewswire.com/apac/zh/news-releases/csa-302401260.html